Synaptive Medical said Tuesday it won Health Canada approval for its BrightMatter Guide brain imaging system.
BrightMatter gives 3D visuals of the brain in the operating room, which help guide surgeons as they pursue neurological procedures. During surgery, the images are placed over an anatomical scan, offering a way to visualize the inside of the brain.
“We are honoured to be able to bring BrightMatter to patients in our home country, which has generated international recognition for developing global game-changing medical technology and impacting patient care. As we continue to meet the needs of our customers, we look forward to collaborative insight from leading physicians who are in our own backyard,” prez Cameron Piron said in a press release
In May, Synaptive said it won FDA 510(k) clearance for its ImageDrive Pro informatics system designed to integrate its existing BrightMatter technology into multiple platforms.
The company said the new platform will allow for interoperability across all of BrightMatter’s solutions, including imaging, surgical planning, navigation and automated positioning of high definition optics.
In April, Synaptic Medical said it won FDA clearance to start marketing its neurosurgery-specific surgical navigation tech for use in U.S. operating rooms.
The company said its BrightMatter Guide system cleared this regulatory sign-off after “months of review.” The company is also moving toward strategic expansion. Earlier in March, it bought up Clear Canvas for an undisclosed price, gaining access to its imaging informatics technologies and a customer base of about 30,000 healthcare professionals around the world.